Written by Klarity Editorial Team
Published: Jun 1, 2026

Finding the right online mental health provider shouldn’t feel like navigating a minefield. Yet in 2026, the telehealth landscape looks drastically different than it did just a few years ago—and understanding your options matters more than ever.
Whether you’re in California struggling with ADHD, a Florida resident exploring anxiety treatment, or someone in New York seeking transparent mental healthcare, this guide breaks down which providers actually serve your state, what medications they’ll prescribe (or won’t), and what you’ll really pay.
The online mental health boom of 2020-2021 promised easy access to care. But by 2026, the industry has matured through regulatory scrutiny, provider shutdowns, and a necessary reckoning around prescribing practices.
What happened? Two major ADHD-focused platforms—Done and Ahead—either shut down or face serious legal challenges. Done’s executives were indicted in 2024 for allegedly over-prescribing stimulants, while Ahead closed its doors in 2022. Even Cerebral, once a telehealth darling, stopped prescribing ADHD stimulants entirely after federal scrutiny and paid $3.6 million in fines for past practices.
The silver lining? This shake-up has created space for more responsible, patient-centered care. Today’s leading providers focus on legitimate treatment rather than quick prescriptions. For patients seeking mental health support, this means choosing from platforms that prioritize safety without sacrificing accessibility.
Good news first: most major telehealth platforms now operate nationwide, including in the six most populous states.
| Provider | CA | TX | FL | NY | PA | IL | Total States |
|---|---|---|---|---|---|---|---|
| Cerebral | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | 50 |
| Brightside | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | 50 |
| Talkiatry | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | 43 |
| PlushCare | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | 50 |
| MDLive | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | 50 |
| Teladoc | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | 50 |
| Amwell | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | 50 |
| Hims/Hers | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | 50 |
| Done | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | Inactive |
| Ahead | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | Closed 2022 |
Note: While Done’s website remains live, the platform is effectively inactive following federal prosecution. Ahead permanently closed operations in 2022.
Here’s where things get complicated—and where patients often feel frustrated. Not all telehealth platforms prescribe the same medications, especially controlled substances.
| Provider | ADHD Stimulants (Adderall, Ritalin) | Anti-Anxiety Benzos (Xanax, Ativan) | Sleep Meds (Ambien, Lunesta) | Weight Loss (GLP-1s) |
|---|---|---|---|---|
| Cerebral | ❌ No (stopped 2022) | ❌ No | ❌ No | ❌ No |
| Brightside | ❌ No (doesn’t treat ADHD) | ❌ No | ❌ No | ❌ No |
| Talkiatry | ✅ Yes (when appropriate) | ✅ Yes (when appropriate) | ✅ Yes (when appropriate) | ❌ No |
| PlushCare | ❌ No | ❌ No | ❌ No | ✅ Yes (for medical reasons) |
| MDLive | ❌ No | ❌ No | ❌ No | ⚠️ Limited (diabetes only) |
| Teladoc | ❌ No | ❌ No | ❌ No | ❌ No |
| Amwell | ❌ No | ❌ No | ❌ No | ⚠️ Limited |
| Hims/Hers | ❌ No | ❌ No | ❌ No | ✅ Yes |
The tightening of prescribing policies isn’t arbitrary. Following the Ryan Haight Act waiver extension (allowing controlled substance tele-prescribing during COVID), federal agencies scrutinized how platforms prescribed addictive medications.
The result: Most direct-to-consumer telehealth companies now avoid controlled substances entirely. Only full-service psychiatric platforms like Talkiatry—where board-certified psychiatrists provide comprehensive evaluations—still prescribe stimulants, benzodiazepines, and sleep medications when medically warranted.
This creates a real gap for patients who legitimately need these medications but want the convenience of telehealth.
Pricing varies dramatically between subscription-based, insurance-based, and pay-per-visit models.
| Provider | Initial Visit | Follow-Up Visits | Monthly Cost | Insurance Accepted? |
|---|---|---|---|---|
| Cerebral | N/A | N/A | $99–$365/month | Limited plans |
| Brightside | N/A | N/A | $95–$349/month | Yes (nationwide) |
| Talkiatry | ~$250–$300 | ~$150 | N/A (per visit) | Yes (in-network) |
| PlushCare | $129 | $129 | $19.99 membership | Yes (most plans) |
| MDLive | $0–$82 | $0–$82 | N/A | Yes (widely) |
| Teladoc | $75–$95 | $75–$95 | N/A | Yes (widely) |
| Amwell | ~$79–$99 | ~$79–$99 | N/A | Yes (many plans) |
| Hims/Hers | N/A | N/A | $85/month | No (cash/HSA) |
Subscription platforms (Cerebral, Brightside, Hims/Hers) bundle services into monthly fees. While convenient, patients often pay whether they need a visit that month or not. Cancellation difficulties and surprise billing have been common complaints.
Insurance-based providers (Talkiatry, MDLive, Teladoc) typically cost less per visit if you have coverage—often just a copay. However, wait times can stretch to 1-3 weeks for initial appointments, and you’re subject to insurance network limitations.
This is where Klarity Health differentiates itself. With transparent pricing—$149 for initial evaluations, $59 for follow-ups, and $25 for prescription refill requests—Klarity offers predictability without locking you into subscriptions. You pay only when you need care, making it competitive for self-pay patients and those with high-deductible plans.
Status: Operating but drastically changed
Best for: Depression and anxiety (not ADHD)
Conditions: Depression, anxiety, insomnia, bipolar, PTSD
Notable: Stopped all new ADHD stimulant prescriptions in May 2022
Once a fast-growing startup, Cerebral now takes what it calls a ‘conservative approach’ to prescribing. After paying $3.6 million in settlements and facing intense scrutiny over its previous practices, the company refocused on non-controlled medications for depression and anxiety.
Patient perspective: Former patients report frustration with sudden medication changes and difficulty getting provider responses. While the platform has improved compliance, it’s no longer the go-to for ADHD treatment.
Status: Under federal indictment
Best for: No longer recommended
Done’s aggressive growth strategy—primarily focused on quick ADHD stimulant prescriptions—ended in June 2024 when federal prosecutors indicted its top executives. The company allegedly generated over 40 million Adderall pills with insufficient oversight, leading to what prosecutors called systematic fraud.
Patient impact: Thousands of patients were left scrambling for care when pharmacies began refusing Done prescriptions even before the formal shutdown. It’s a stark reminder that ‘easy access’ to controlled medications often comes with serious risks.
Status: Active and growing
Best for: Depression, anxiety, OCD, PTSD, insomnia (no ADHD)
Pricing: $95/month (medication), $349/month (therapy + medication)
Insurance: Yes, nationwide coverage
Brightside positions itself as the safe, evidence-based alternative. The company explicitly doesn’t diagnose or treat ADHD and prescribes no controlled substances—only SSRIs, SNRIs, and similar non-addictive medications.
Who it’s for: Patients seeking treatment for depression or anxiety who prefer avoiding controlled medications. The platform offers psychiatric care plus optional therapy in a subscription model.
Limitations: If you need ADHD treatment or have anxiety that hasn’t responded to first-line medications, Brightside simply can’t help. Many patients appreciate this transparency, but it’s a significant service gap.
Status: Active, rapidly expanding
Best for: Comprehensive psychiatric care including ADHD
Pricing: Insurance copays (typically $25–$50) or $250–$400/visit self-pay
Insurance: Yes, in-network with major plans
Talkiatry operates more like a traditional psychiatry practice that happens to be online. Board-certified psychiatrists conduct thorough evaluations and can prescribe any appropriate medication, including stimulants and benzodiazepines when clinically warranted.
Advantages: Legitimate psychiatric care without the ‘quick prescription’ stigma. The platform recently expanded to adolescent psychiatry in 31 states, showing its commitment to comprehensive mental health.
Drawbacks: Wait times for initial appointments can stretch to several weeks due to high demand. Insurance coverage is excellent, but changing providers or scheduling can involve typical insurance bureaucracy.
Status: Active
Best for: General medical needs with mild anxiety/depression
Pricing: $19.99/month membership + $129/visit
Insurance: Yes, most plans
PlushCare started as a general telehealth platform for sinus infections and flu-like symptoms. Mental health is a newer offering, and it shows—the platform explicitly won’t prescribe any controlled substances, including ADHD medications or benzodiazepines.
Unique offering: PlushCare does prescribe GLP-1 medications (like Ozempic/Wegovy) for weight loss when medically appropriate, which most mental health platforms don’t touch.
Who it’s for: Patients who need a primary care provider plus mild mental health support in one platform.
These telehealth giants all follow similar models—broad coverage, insurance-based, and highly restrictive on psychiatric medications.
MDLive, Teladoc, and Amwell will NOT prescribe:
What they’re good for: Urgent care needs, general health issues, and mild depression/anxiety where an SSRI is appropriate. Many employers and insurance plans include these services at low or no cost.
Psychiatric care limitations: These platforms work well for follow-ups if you already have a diagnosis and stable medication regimen. For new psychiatric diagnoses requiring controlled medications, you’ll need a specialist like Talkiatry or Klarity.
Status: Active, expanding
Best for: Anxiety, depression, hair loss, ED, weight loss
Pricing: $85/month for mental health; separate pricing for other services
Insurance: No (cash/HSA only)
Hims & Hers carved out a unique niche by combining mental health with wellness and lifestyle medicine. In 2023, they launched GLP-1 weight loss programs, putting them at the intersection of psychiatric and metabolic health.
Mental health approach: The platform prescribes SSRIs and similar non-controlled medications for anxiety and depression. No ADHD medications or benzodiazepines.
2025 FDA warning: Hims received FDA warning letters about marketing compounded semaglutide for weight loss, highlighting the regulatory scrutiny around telehealth weight management.
Who it’s for: Patients comfortable with cash-pay, lifestyle-oriented care who want multiple services (mental health + hair loss + weight management) in one platform.
The ideal platform depends on your specific needs:
After years of turbulence in the telehealth industry, patients deserve providers who balance accessibility with responsibility. This is where Klarity Health has positioned itself strategically.
What makes Klarity different:
Comprehensive psychiatric care without the subscription trap. Unlike Cerebral or Brightside’s monthly fees, Klarity’s transparent pricing ($149 initial, $59 follow-up) means you pay only for care you receive.
Willing to prescribe necessary controlled medications responsibly. While most platforms simply say ‘no’ to all Schedule II or IV drugs, Klarity’s providers can prescribe ADHD stimulants, appropriate anxiety medications, or sleep aids when clinically warranted—following proper evaluation and ongoing monitoring.
Faster access than insurance-based alternatives. Talkiatry’s wait times can stretch to weeks. Klarity typically offers appointments within days, addressing the urgency many patients feel when seeking mental health care.
Both insurance and cash-pay options. Klarity accepts insurance for those who have coverage, but also maintains clear self-pay pricing for patients with high deductibles or no mental health benefits. This flexibility is increasingly rare as providers pick one model or the other.
Specialized conditions others ignore. From PMDD to binge eating disorder to low testosterone, Klarity treats the full spectrum of adult mental and metabolic health—not just anxiety and depression.
The telehealth landscape will continue evolving through 2026 and beyond. Key trends to watch:
Regulatory changes: The Ryan Haight Act waiver allowing controlled substance tele-prescribing was extended through December 2025, but its future remains uncertain. Providers may need to incorporate occasional in-person visits or partner with local clinics to comply with potential new rules.
Consolidation continues: Weaker startups will likely be acquired by larger healthcare entities. This could mean fewer independent options but potentially better integration with insurance and electronic health records.
Hybrid care models: The most successful platforms will probably blend telehealth convenience with in-person touchpoints when needed—avoiding both the ‘pill mill’ perception and the pure virtual model’s limitations.
Metabolic and mental health integration: The boundary between psychiatric care and metabolic health (obesity, diabetes, hormones) is blurring. Forward-thinking providers will offer comprehensive wellness rather than single-condition treatment.
Q: Can I get Adderall prescribed online in 2026?
A: Yes, but through limited channels. Most general telehealth platforms (Teladoc, PlushCare, Amwell) don’t prescribe ADHD stimulants. You’ll need a specialized psychiatric service like Talkiatry or Klarity Health, where providers conduct thorough evaluations before determining appropriate treatment.
Q: Why did Cerebral stop prescribing ADHD medications?
A: Following federal scrutiny in 2022 over prescribing practices, Cerebral halted all new stimulant prescriptions and paid $3.6 million in settlements. The company now focuses on non-controlled medications for anxiety and depression.
Q: Which telehealth providers accept insurance?
A: Talkiatry, MDLive, Teladoc, Amwell, PlushCare, and Brightside all accept various insurance plans. Klarity Health accepts insurance and offers transparent cash-pay pricing. Hims/Hers is cash-only (HSA/FSA eligible).
Q: What happened to Done and Ahead?
A: Done’s executives were federally indicted in June 2024 for allegedly over-prescribing ADHD stimulants, effectively shutting down operations. Ahead closed in 2022 due to financial and operational challenges. Both cases contributed to increased industry regulation.
Q: Can online providers prescribe Xanax or Ativan?
A: Most cannot. General telehealth platforms prohibit benzodiazepine prescribing. Only full-service psychiatric providers like Talkiatry or Klarity Health can prescribe these medications when clinically appropriate, following comprehensive evaluation.
Q: How much does online psychiatric care typically cost?
A: With insurance, copays range from $0-$50. Without insurance, expect $75-$300 for initial visits and $50-$150 for follow-ups. Subscription services charge $85-$365 monthly. Klarity’s transparent pricing ($149 initial, $59 follow-up) often costs less than monthly subscriptions for occasional-use patients.
Q: What if I need both therapy and medication management?
A: Some platforms bundle these services—Brightside charges $349/month for combined therapy and medication. Alternatively, you can use separate providers (e.g., BetterHelp for therapy, Klarity for medication management), which often costs less and provides more flexibility.
Q: Are telehealth prescriptions legitimate?
A: Yes, when prescribed by licensed providers following appropriate evaluation. However, the Done Global indictment showed that not all telehealth companies operate responsibly. Choose providers with clear prescribing policies, licensed clinicians in your state, and established safety protocols.
The telehealth mental health landscape in 2026 offers more responsible, patient-centered options than the early pandemic boom years—but navigating your choices still requires research.
Key takeaways:
If you’re struggling to find accessible, legitimate mental health care, Klarity Health offers the balance many patients seek: licensed psychiatric providers who take time for thorough evaluations, transparent pricing without subscription traps, and willingness to prescribe necessary medications responsibly.
Most importantly, Klarity provides appointments within days rather than weeks—because when you’re struggling with ADHD, anxiety, depression, or insomnia, waiting weeks for care isn’t acceptable.
Start your evaluation with Klarity Health today and experience the difference that accessible, responsible psychiatric care makes.
This guide is based on extensive research of telehealth providers, regulatory developments, and industry reporting through early 2026. Key sources include:
AP News – ‘DOJ indicts Done Global executives for ADHD medication over-prescribing scheme’ (June 14, 2024). Associated Press reporting on federal prosecution of Done’s leadership for allegedly distributing 40+ million Adderall pills with inadequate oversight. [Source: apnews.com]
TIME Magazine – ‘Why Online Therapy Startups Like Cerebral, Done, and Ahead Are Falling Short’ (November 1, 2022). Investigative journalism examining the telehealth boom, regulatory challenges, and company shutdowns including Ahead’s 2022 closure. [Source: time.com]
TechTarget Healthcare IT News – ‘Pushing ADHD telehealth prescriptions costs Cerebral millions’ (November 6, 2024). Industry analysis of Cerebral’s $3.6M settlement with federal agencies over controlled substance prescribing practices and the company’s policy changes. [Source: techtarget.com]
Teladoc Health – Official prescription policy FAQ (updated 2023). Company policy documentation explicitly stating Teladoc does not prescribe Schedule II stimulants, benzodiazepines, or certain sleep medications via telehealth visits. [Source: teladochealth.com]
Brightside Health – Medication prescribing FAQ and pricing information (updated 2025). Official company documentation of formulary limitations (no controlled substances), conditions treated (excluding ADHD), and subscription pricing structure ($95-$349/month). [Source: brightside.com]
Research currency verified as of January 2026. All provider availability, pricing, and prescribing policies reflect publicly available information from official company sources, regulatory filings, and reputable healthcare journalism. Individual experiences may vary based on location, insurance coverage, and clinical circumstances.
Find the right provider for your needs — select your state to find expert care near you.